Aristides Capital’s Compugen CGEN Stock Holding History

Aristides Capital’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-15,403	Closed	-$187K	–	134
2020 Q4	$187K	Buy	+15,403	New	+$212K	0.06%	130

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Aristides Capital's CGEN Position: Q1 2021 in Review

Aristides Capital sold out of Compugen (CGEN) in Q1 2021, closing a stake of 15,403 shares — an estimated $187K sold.

Aristides Capital first reported a position in CGEN in Q4 2020 and held it in 1 quarter. The position peaked at $187K in Q4 2020. 108 funds tracked by Wall St. Rank hold CGEN as of Q1 2021.

Aristides Capital reported no remaining Compugen position as of Q1 2021 after selling out during the quarter.
Aristides Capital sold 15,403 Compugen shares in Q1 2021, an estimated $187K.
Aristides Capital first reported a position in Compugen in Q4 2020 and held it in 1 quarter.
Aristides Capital's Compugen position peaked at $187K in Q4 2020.
108 funds tracked by Wall St. Rank held Compugen as of Q1 2021.

Based on Aristides Capital's 13F filing for Q1 2021, filed 17 May 2021.